ABSTRACT

Conclusion:

Re-TUR allows more accurate staging and effective treatment for patients with T1 high-grade bladder cancer in whom radical cystectomy can be a more effective treatment option.

Results:

Six patients (6.6%) were re-staged as T2 according to the histopathological analysis of re-TUR specimens. The incidence of residual tumor following re-TUR performed by experienced surgeons was not statistically significant (p>0.05).

Materials and Methods:

A total of 90 with the diagnosis of grade pTa and all pT1 bladder cancer were included in the study. Re-TUR was performed in all patients 2-6 weeks after the initial TUR.

Objective:

In this study, we aimed to investigate the importance of repeat-transurethral resection (re-TUR) in bladder cancer treatment.